TABLE 2.
List of the top 50 human proteins putatively enriched at the Toxoplasma parasitophorous vacuole membranea
Accession no. | Description | Gene | mT-RAH + Toxo/mT-RAH + mock log2 FC |
---|---|---|---|
Q5VSL9 | Striatin-interacting protein 1 | STRIP1 | 2.13 |
O75340-2 | Isoform 2 of programmed cell death protein 6 | PDCD6 | 2.00 |
A0A0C4DH65 | Protein KRBA1 | KRBA1 | 1.72 |
Q8NHP6 | Motile sperm domain-containing protein 2 | MOSPD2 | 1.70 |
Q6P1N0 | Coiled-coil and C2 domain-containing protein 1A | CC2D1A | 1.67 |
Q6N043 | Zinc finger protein 280D | ZNF280D | 1.66 |
P49750 | Isoform 4 of YLP motif-containing protein 1 | YLPM1 | 1.53 |
Q5T0F9 | Coiled-coil and C2 domain-containing protein 1B | CC2D1B | 1.51 |
A6NMQ1 | DNA polymerase | POLA1 | 1.46 |
Q6P1N0-2 | Isoform 2 of coiled-coil and C2 domain-containing protein 1A | CC2D1A | 1.41 |
Q6PJI9 | GATOR complex protein WDR59 | WDR59 | 1.39 |
Q99816 | Tumor susceptibility gene 101 protein | TSG101 | 1.37 |
Q7Z460 | CLIP-associating protein 1 | CLASP1 | 1.18 |
Q99570 | Phosphoinositide 3-kinase regulatory subunit 4 | PIK3R4 | 1.18 |
Q99661 | Kinesin-like protein KIF2C | KIF2C | 1.16 |
Q9NYA1-2 | Isoform 2 of sphingosine kinase 1 | SPHK1 | 1.13 |
P21580 | Tumor necrosis factor alpha-induced protein 3 | TNFAIP3 | 1.12 |
Q07960 | Rho GTPase-activating protein 1 | ARHGAP1 | 1.05 |
Q8NDZ4 | Deleted in autism protein 1 | DIPK2A | 0.97 |
Q9P273 | Teneurin-3 | TENM3 | 0.96 |
Q9Y2K6 | Ubiquitin carboxyl-terminal hydrolase 20 | USP20 | 0.95 |
Q8TEY7 | Ubiquitin carboxyl-terminal hydrolase 33 | USP33 | 0.85 |
P15408 | Fos-related antigen 2 | FOSL2 | 0.84 |
P17275 | Transcription factor jun-B | JUNB | 0.78 |
P15407 | Fos-related antigen 1 | FOSL1 | 0.75 |
Q8WUM4 | Programmed cell death 6-interacting protein | PDCD6IP | 0.72 |
Q14BN4 | Sarcolemmal membrane-associated protein | SLMAP | 0.71 |
Q9UK41 | Vacuolar protein sorting-associated protein 28 homolog | VPS28 | 0.67 |
Q86VY9 | Transmembrane protein 200A | TMEM200A | 0.67 |
P18850 | Cyclic AMP-dependent transcription factor ATF-6 alpha | ATF6 | 0.65 |
Q6UWP8 | Suprabasin | SBSN | 0.64 |
O94822-3 | Isoform 3 of E3 ubiquitin-protein ligase listerin | LTN1 | 0.64 |
O75154-3 | Isoform 3 of Rab11 family-interacting protein 3 | RAB11FIP3 | 0.62 |
P53985 | Monocarboxylate transporter 1 | SLC16A1 | 0.62 |
Q96F4 | Interleukin-17 receptor A | IL17RA | 0.62 |
Q9NU22 | Midasin | MDN1 | 0.59 |
Q96JA1 | Leucine-rich repeats and immunoglobulin-like domains protein 1 | LRIG1 | 0.57 |
P35475 | Alpha-l-iduronidase | IDUA | 0.50 |
O95983 | Methyl-CpG-binding domain protein 3 | MBD3 | 0.49 |
Q5D862 | Filaggrin-2 | FLG2 | 0.48 |
Q9NYI0 | PH and SEC7 domain-containing protein 3 | PSD3 | 0.48 |
P32189 | Glycerol kinase | GK | 0.46 |
Q9BTX7 | Alpha-tocopherol transfer protein-like | TTPAL | 0.45 |
P53794 | Sodium/myo-inositol cotransporter | SLC5A3 | 0.44 |
P30048 | Thioredoxin-dependent peroxide reductase mitochondrial | PRDX3 | 0.43 |
Q9C0C4 | Semaphorin-4C | SEMA4C | 0.43 |
P40189 | Interleukin-6 receptor subunit beta | IL6ST | 0.43 |
P29590-2 | Isoform PML-5 of Protein PML | PML | 0.43 |
P02786 | Transferrin receptor protein 1 | TFRC | 0.42 |
Q9H444 | Charged multivesicular body protein 4b | CHMP4B | 0.42 |
The relative abundance of each protein was determined across all samples using the peptide-level TMT quantification, and the log2 fold change (log2 FC) was determined for various sample ratios. The proteins were first filtered by requiring a minimum log2 FC of −0.65 for the (mT-RAH + Toxo)/(mT + Toxo) ratio and a log2 FC of 0 for the (mT-RAH + Toxo/mT-RAH + Toxo, no biotin) ratio (see Materials and Methods). Displayed here are the top 50 human proteins (identified by at least 2 unique peptides, with a protein score of >25, and with a protein coverage of >1%) ranked according to the log2 FC between the averaged mT-RAH + Toxo samples versus mT-RAH + mock samples. Also shown are their majority human UniProt identifiers (“Accession Number” column), i.e., the proteins that contain at least half of the peptides belonging to a group of proteins that cannot be unambiguously identified by unique peptides, the descriptive name for each protein (“Description” column), and the gene symbol (“Gene” column). The proteins of unknown location in infected cells chosen for follow-up localization studies are bolded.